Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
Cancer Research
|
October 1, 1987
Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemia
P A Paciucci, C Keaveney, J Cuttner, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1980
Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells
P A Paciucci, S Macphail, J M Zarling, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1980
Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells
P A Paciucci, S Macphail, F H Bach, et al.
Lancet (London, England)
|
April 20, 1974
Letter: Influence of Hodgkin's serum on P.H.A. stimulation of normal lymphocytes
C O Zorini, A Neri, M Comis, et al.
The American Journal of Medicine
|
September 1, 1990
Thrombocytopenia during immunotherapy with interleukin-2 by constant infusion
P A Paciucci, J Mandeli, L Oleksowicz, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1984
Detection and quantification of mitoxantrone in human organs. A case report
J Roboz, P A Paciucci, D Silides, et al.
Cancer Investigation
|
January 1, 1995
Increase of plasma transforming growth factor beta (TGF beta) during immunotherapy with IL-2
P Puolakkainen, D Twardzik, J Ranchalis, et al.
Cancer Treatment Reviews
|
December 1, 1983
Mitoxantrone in acute lymphoblastic leukemia
P A Paciucci, T Ohnuma, J Cuttner, et al.
Cancer Research
|
August 1, 1983
Mitoxantrone in patients with acute leukemia in relapse
P A Paciucci, T Ohnuma, J Cuttner, et al.
American Journal of Clinical Oncology
|
December 1, 1990
Mitoxantrone and constant infusion etoposide for relapsed and refractory acute myelocytic leukemia
P A Paciucci, R B Davis, J F Holland, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
Cancer Research
|
October 1, 1987
Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemia
P A Paciucci, C Keaveney, J Cuttner, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1980
Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells
P A Paciucci, S Macphail, J M Zarling, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1980
Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells
P A Paciucci, S Macphail, F H Bach, et al.
Lancet (London, England)
|
April 20, 1974
Letter: Influence of Hodgkin's serum on P.H.A. stimulation of normal lymphocytes
C O Zorini, A Neri, M Comis, et al.
The American Journal of Medicine
|
September 1, 1990
Thrombocytopenia during immunotherapy with interleukin-2 by constant infusion
P A Paciucci, J Mandeli, L Oleksowicz, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1984
Detection and quantification of mitoxantrone in human organs. A case report
J Roboz, P A Paciucci, D Silides, et al.
Cancer Investigation
|
January 1, 1995
Increase of plasma transforming growth factor beta (TGF beta) during immunotherapy with IL-2
P Puolakkainen, D Twardzik, J Ranchalis, et al.
Cancer Treatment Reviews
|
December 1, 1983
Mitoxantrone in acute lymphoblastic leukemia
P A Paciucci, T Ohnuma, J Cuttner, et al.
Cancer Research
|
August 1, 1983
Mitoxantrone in patients with acute leukemia in relapse
P A Paciucci, T Ohnuma, J Cuttner, et al.
American Journal of Clinical Oncology
|
December 1, 1990
Mitoxantrone and constant infusion etoposide for relapsed and refractory acute myelocytic leukemia
P A Paciucci, R B Davis, J F Holland, et al.
Page
of 4